204 related articles for article (PubMed ID: 6130805)
21. [Effect of Morinda lucida Benth. (Rubiaceae) and Newbouldia leavis P. Beauv. (Bignoniaceae) on sickling of red blood cells].
Joppa KM; Vovor A; Eklu-Gadegbeku K; Agbonon A; Aklikokou K; Gbeassor M
Med Trop (Mars); 2008 Jun; 68(3):251-6. PubMed ID: 18689316
[TBL] [Abstract][Full Text] [Related]
22. Antisickling activity of anthocyanins from Bombax pentadrum, Ficus capensis and Ziziphus mucronata: photodegradation effect.
Mpiana PT; Mudogo V; Tshibangu DS; Kitwa EK; Kanangila AB; Lumbu JB; Ngbolua KN; Atibu EK; Kakule MK
J Ethnopharmacol; 2008 Dec; 120(3):413-8. PubMed ID: 18930798
[TBL] [Abstract][Full Text] [Related]
23. Anti-sickling potential of a Nigerian herbal formula (ajawaron HF) and the major plant component (Cissus populnea L. CPK).
Moody JO; Ojo OO; Omotade OO; Adeyemo AA; Olumese PE; Ogundipe OO
Phytother Res; 2003 Dec; 17(10):1173-6. PubMed ID: 14669251
[TBL] [Abstract][Full Text] [Related]
24. Survival rates and properties of sickle cell anemia red cells treated with nitrogen mustard.
Roth EF; Wenz B; Lee HB; Fabry M; Chang H; Kaul DK; Baez S; Nagel RL
Prog Clin Biol Res; 1987; 240():245-61. PubMed ID: 3615491
[TBL] [Abstract][Full Text] [Related]
25. Effects of methyl acetyl phosphate, a covalent antisickling agent, on the density profiles of sickle erythrocytes.
Ueno H; Yatco E; Benjamin LJ; Manning JM
J Lab Clin Med; 1992 Jul; 120(1):152-8. PubMed ID: 1613320
[TBL] [Abstract][Full Text] [Related]
26. The kinetics of reversal of pre-sickled erythrocytes by the aqueous extract of Cajanus cajan seeds.
Ogoda Onah J; Akubue PI; Okide GB
Phytother Res; 2002 Dec; 16(8):748-50. PubMed ID: 12458479
[TBL] [Abstract][Full Text] [Related]
27. Drug action hypothesis: how membrane expansion, calmodulin inhibition, and sickle cell therapy relate.
Brewer GJ; Bereza U; Mizukami I; Aster JC; Brewer LF
Prog Clin Biol Res; 1981; 55():187-211. PubMed ID: 6117079
[No Abstract] [Full Text] [Related]
28. Cetiedil-induced increase in water exchange in sickle cell anemia erythrocytes.
Narasimhan C; Fung LW
J Pharm Sci; 1991 Nov; 80(11):1101-2. PubMed ID: 1815064
[No Abstract] [Full Text] [Related]
29. Membrane expansion as a mechanism explaining the antisickling action of ticlopidine observed in vitro.
Sablayrolles M; Wajcman H; Castaigne JP; Labie D
Am J Hematol; 1985 Feb; 18(2):121-30. PubMed ID: 3970009
[TBL] [Abstract][Full Text] [Related]
30. [Protective effect of buflomedil hydrochloride on erythrocyte sickling. In vitro study].
Briguglio F; Briguglio E; Di Marco V
Minerva Med; 1986 Feb; 77(7-8):249-62. PubMed ID: 3951731
[TBL] [Abstract][Full Text] [Related]
31. In vitro study of ticlopidine, as a model of antisickling action of platelet antiaggregant.
Sablayrolles M; Wajcman H; Castaigne JP; Labie D
Haematologia (Budap); 1984; 17(2):199-207. PubMed ID: 6534828
[TBL] [Abstract][Full Text] [Related]
32. Effect of anti-adhesive drugs on red cell sickling in vitro.
Bicher HI; Padilla F; Van Wagner WH
Bibl Anat; 1975; 13():127-8. PubMed ID: 1231698
[No Abstract] [Full Text] [Related]
33. The molecular basis of antisickling agents.
Franklin IM; Huehns ER
Trans R Soc Trop Med Hyg; 1980; 74(6):695-700. PubMed ID: 7210123
[No Abstract] [Full Text] [Related]
34. Spin-label study of phenothiazine interactions with erythrocyte ghost membranes: a possible membrane-mediated antisickling action.
Jones GL; Woodbury DM
J Pharmacol Exp Ther; 1978 Oct; 207(1):203-11. PubMed ID: 702341
[TBL] [Abstract][Full Text] [Related]
35. Pharmaco-proteomic study of hydroxyurea-induced modifications in the sickle red blood cell membrane proteome.
Ghatpande SS; Choudhary PK; Quinn CT; Goodman SR
Exp Biol Med (Maywood); 2008 Dec; 233(12):1510-7. PubMed ID: 18849548
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of erythrocyte sickling in vitro by pyridoxal.
Kark JA; Kale MP; Tarassoff PG; Woods M; Lessin LS
J Clin Invest; 1978 Oct; 62(4):888-91. PubMed ID: 701485
[TBL] [Abstract][Full Text] [Related]
37. Effect of cetiedil, an in vitro antisickling agent, on erythrocyte membrane cation permeability.
Berkowitz LR; Orringer EP
J Clin Invest; 1981 Nov; 68(5):1215-20. PubMed ID: 7298848
[TBL] [Abstract][Full Text] [Related]
38. Design, synthesis, and testing of potential antisickling agents. 6. Rheologic studies with active phenoxy and benzyloxy acids.
Patwa DC; Abraham DJ; Hung TC
Blood Cells; 1987; 12(3):589-601. PubMed ID: 3651614
[TBL] [Abstract][Full Text] [Related]
39. Understanding antisickling agents and the sickling process.
Godwin M; Baysinger M
Nurs Clin North Am; 1983 Mar; 18(1):207-14. PubMed ID: 6550864
[No Abstract] [Full Text] [Related]
40. The increasing complexity of sickle cell anemia.
Warth JA; Rucknagel DL
Prog Hematol; 1983; 13():25-47. PubMed ID: 6199811
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
